Efficacy and safety of lebrikizumab for the treatment of moderate-to-severe atopic dermatitis: a systematic review and meta-analysis

Efficacy and safety of lebrikizumab for the treatment of moderate-to-severe atopic dermatitis: a systematic review and meta-analysis

BackgroundLebrikizumab, an IL-13 immunomodulator, has shown recommendable effectiveness and safety in clinical studies for the treatment of moderate-to-severe atopic dermatitis (AD) in adolescents and adults.ObjectiveTo evaluate the efficacy and safety of lebrikizumab in the treatment of moderate-to...

Full description

Saved in:
Bibliographic Details
Main Authors: Jinger Lin, Min Luo, Qianwei Zhuo, Nuo Chen, Haosong Zhang, Yue Han
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-11-01
Series:Frontiers in Pharmacology
Subjects:
lebrikizumab
meta-analysis
atopic dermatitis
efficacy
safety
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1429709/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2024.1429709/full

Similar Items